Medical device and technology company Vivos Therapeutics, Inc. (VVOS) announced Wednesday two key strategic agreements with Ormco, a division of Envista Holdings Corp. (NVST), and On Demand Orthodontist to provide Spark Clear Aligners.
The deals will expand Vivos' current product line and will create near term significant additional revenue opportunities.
In pre-market activity on Nasdaq, Vivos shares were gaining around 65 percent
Kirk Huntsman, Vivos' Chairman and Chief Executive Officer, said, "Spark Aligners are rapidly becoming the go-to clear aligner of choice for orthodontic specialists. … This agreement facilitates a strong collaboration effort between Vivos and Ormco, and paves the way for joint marketing and sales support from each company's field sales teams. Using Vivos CARE devices with Spark Aligners, we expect Vivos patients to see faster treatment times and improved predictability for positive clinical outcomes."
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.